Otsuka's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of delamanid.

Six members of the G20 are among the 22 countries with the highest burden of tuberculosis: Brazil, China, India, Indonesia, Russia and South Africa.

Xpert, once introduced and widely scaled-up, is expected to dramatically reduce the diagnostic gaps for tuberculosis, in particular in its multi-drug resistant form, or associated with an HIV infection.

International consultation convened in conjunction with AIDS 2012
Date: 21 July 2012
Time: 09:00 – 17:00
Location: Rm. 202, Georgetown Law, 600 New Jersey Ave., NW, McDonough Hall, Washington, DC 20001

3rd Annual South African TB Conference, Durban 2012
Date: 14 June 2012
Time: 14h00 – 15h30
Location: Hall 3B

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam.

Janssen's response to TB CAB letter regarding pharmacokinetic studies, paediatric studies, and compassionate use of bedaquiline.

WHO is working with countries to identify opportunities for expansion of treatment in line with its 2010 guidelines, which recommended treatment for all people living with HIV with CD4 cell counts below 350, all infants below the age of 2, and for everyone with TB and HIV or hepatitis B and HIV coinfection.

Russia currently ranks third by the number of multidrug-resistant TB cases worldwide after China and India, countries with vastly larger populations.